Among patients with HER2+ breast cancer, CRP and SAA levels exhibited a moderate degree of correlation (0.423), while IL-6 levels exhibited little to no correlation with CRP (0.285) or SAA (−0.084). The gene discussed is CRP; the disease is breast carcinoma.